Healthcare Holding B.V. Gilde Sells 20,516 Shares of Shoulder Innovations (NYSE:SI) Stock

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 20,516 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $22.61, for a total value of $463,866.76. Following the sale, the insider directly owned 2,187,791 shares of the company’s stock, valued at approximately $49,465,954.51. The trade was a 0.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Monday, August 24th, Healthcare Holding B.V. Gilde sold 681 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.62, for a total value of $15,404.22.
• On Thursday, August 20th, Healthcare Holding B.V. Gilde sold 3,900 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total transaction of $88,140.00.
• On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total transaction of $47,347.00.
• On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.64, for a total transaction of $166,132.32.
• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.77, for a total transaction of $2,272,719.24.
• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.71, for a total value of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.73, for a total value of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total value of $659,803.20.

Shoulder Innovations Stock Up 0.8%

Shoulder Innovations stock traded up $0.18 during midday trading on Monday, reaching $22.24. The stock had a trading volume of 75,051 shares, compared to its average volume of 128,345. The company has a current ratio of 10.71, a quick ratio of 8.92 and a debt-to-equity ratio of 0.12. Shoulder Innovations, Inc. has a 12 month low of $10.92 and a 12 month high of $24.59. The company has a fifty day moving average price of $21.03 and a two-hundred day moving average price of $16.60. The company has a market capitalization of $463.02 million and a P/E ratio of -11.58.

Shoulder Innovations (NYSE:SI) last released its quarterly earnings results on Thursday, August 6th. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.46) by ($0.03). The firm had revenue of $17.18 million for the quarter. Shoulder Innovations had a negative return on equity of 23.61% and a negative net margin of 58.33%. As a group, equities analysts expect that Shoulder Innovations, Inc. will post -1.9 EPS for the current fiscal year.

Institutional Trading of Shoulder Innovations

Hedge funds have recently made changes to their positions in the business. Sectoral Asset Management Inc. lifted its position in shares of Shoulder Innovations by 14.4% during the fourth quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company’s stock worth $7,042,000 after purchasing an additional 62,153 shares during the last quarter. Deerfield Management Company L.P. bought a new stake in Shoulder Innovations during the third quarter valued at about $6,056,000. Alyeska Investment Group L.P. bought a new position in shares of Shoulder Innovations during the 3rd quarter worth approximately $5,667,000. Roubaix Capital LLC boosted its position in shares of Shoulder Innovations by 61.9% in the 1st quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock worth $3,736,000 after purchasing an additional 98,305 shares in the last quarter. Finally, Vanguard Group Inc. acquired a new stake in Shoulder Innovations in the third quarter worth about $1,836,000.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Piper Sandler reissued an “overweight” rating and issued a $25.00 target price (up from $19.00) on shares of Shoulder Innovations in a research note on Friday, August 7th. Weiss Ratings raised shares of Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a report on Monday, August 3rd. BTIG Research boosted their target price on shares of Shoulder Innovations from $24.00 to $26.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Finally, UBS Group raised their price objective on Shoulder Innovations from $27.00 to $28.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. Six equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $23.50.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.